行情

AMPH

AMPH

Amphastar制药
NASDAQ

实时行情|Nasdaq Last Sale

19.67
-0.01
-0.05%
交易中 13:18 01/28 EST
开盘
19.78
昨收
19.68
最高
19.99
最低
19.64
成交量
8.38万
成交额
--
52周最高
25.43
52周最低
16.71
市值
9.23亿
市盈率(TTM)
18.89
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AMPH 新闻

  • Can You Imagine How Amphastar Pharmaceuticals's (NASDAQ:AMPH) Shareholders Feel About The 54% Share Price Increase?
  • Simply Wall St..01/08 10:15
  • Here is What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH)
  • Insider Monkey.2019/12/18 00:19
  • Momenta to pay $35M to settle Tennessee antitrust case
  • seekingalpha.2019/12/11 03:01
  • Edited Transcript of AMPH earnings conference call or presentation 7-Nov-19 10:00pm GMT
  • Thomson Reuters StreetEvents.2019/12/10 22:46

更多

所属板块

制药
+0.41%
制药与医学研究
+0.57%

热门股票

名称
价格
涨跌幅

AMPH 简况

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.
展开

Webull提供Amphastar Pharmaceuticals Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。